Deferred Tax Assets, Valuation Allowance in USD of PROKIDNEY CORP. from Q4 2021 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
PROKIDNEY CORP. quarterly Deferred Tax Assets, Valuation Allowance history and change rate from Q4 2021 to Q4 2024.
  • PROKIDNEY CORP. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $6,928,000, a 46% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

PROKIDNEY CORP. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $6,928,000 -$5,960,000 -46% 31 Dec 2024 10-K 17 Mar 2025 2024 FY
Q4 2023 $12,888,000 +$9,556,000 +287% 31 Dec 2023 10-K 17 Mar 2025 2024 FY
Q4 2022 $3,332,000 +$2,095,000 +169% 31 Dec 2022 10-K 22 Mar 2024 2023 FY
Q4 2021 $1,237,000 31 Dec 2021 10-K 28 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.